Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease

NCT03947216 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT03947216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03947216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Lead sponsor
University Hospital, Strasbourg, France
Phase
Phase 2
Overall status
Completed
Start date
October 23, 2020
Completion date
June 17, 2024
Enrollment
117 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease